These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 18314883

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.
    Chung HJ, Lee MG.
    Biopharm Drug Dispos; 2006 Oct; 27(7):345-51. PubMed ID: 16902944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of Escherichia coli lipopolysaccharide on telithromycin pharmacokinetics in rats: inhibition of metabolism via CYP3A.
    Lee JH, Cho YK, Jung YS, Kim YC, Lee MG.
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1046-51. PubMed ID: 18160519
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R, Bhateria M, Singh R, Bhatta RS.
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH, Lee MG.
    Life Sci; 2002 Feb 01; 70(11):1299-315. PubMed ID: 11883708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
    Lee DY, Kim JW, Lee MG.
    Eur J Pharm Sci; 2007 Dec 01; 32(4-5):328-39. PubMed ID: 17935951
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    Lee DY, Lee I, Lee MG.
    Int J Pharm; 2007 Feb 07; 330(1-2):37-44. PubMed ID: 16997515
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats.
    Choi MR, Kwon MH, Cho YY, Choi HD, Kim YC, Kang HE.
    Biopharm Drug Dispos; 2014 Jul 07; 35(5):264-74. PubMed ID: 24590592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.